Skip to main content
Premium Trial:

Request an Annual Quote

Without the Feel-Good Aspect

A recent report in Science found that rejected and revised papers often make their way into higher-impact journals where they become more highly cited, which The Scientist characterized as "an upside to this routine disappointment." Casey Bergman, though, blogs at I Wish You'd Made Me Angry Earlier that the difference in median citations between rejected and resubmitted papers and others is minimal.

By examining a graph in the study, Bergman concludes "that papers that are rejected then published elsewhere have a median value of [about] 0.95 citations, whereas papers that are accepted at the first journal they are submitted to have a median value of [about] 0.90 citations." He notes that the scale of the graph is not clear, and, if it is a log10 scale, he says the number of citations that a rejected and resubmitted paper has will increase by less than one. "While statistically significant, this can hardly be described as a 'significant increase' in citation. Still excited?" he asks.

It's the other point of the paper that Bergman says is most interesting — most papers are published by the first journal to which they are submitted. "As a scientific community we should continue to maintain and improve this trend, selecting the appropriate home for our work on initial submission," he says.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.